NCT03683134

Brief Summary

A 12-week, randomized nutrition intervention for the reduction of cardiovascular disease risk factors in a high-risk population in the southeastern United States. The primary objective of this pilot study was to assess the efficacy of a Mediterranean diet intervention (education + extra-virgin olive oil (EVOO) and mixed nut supplementation) versus that of an American Heart Association (AHA) nutrition intervention (education) on serum blood lipid levels as markers for cardiovascular disease risk. Researchers conducting this trial hypothesize that a greater reduction will be seen in cardiovascular disease risk factors in the Mediterranean diet intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Jan 2017

Shorter than P25 for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2017

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 20, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 25, 2018

Completed
Last Updated

September 27, 2018

Status Verified

September 1, 2018

Enrollment Period

8 months

First QC Date

September 20, 2018

Last Update Submit

September 26, 2018

Conditions

Keywords

Cardiovascular DiseaseMediterranean DietNutrition education

Outcome Measures

Primary Outcomes (2)

  • Systolic Blood Pressure Measurement

    Measured in mmHg

    Change from at baseline blood pressure to 6-weeks

  • Systolic Blood Pressure Measurement

    Measured in mmHg

    Change from at baseline blood pressure to 12-weeks

Secondary Outcomes (20)

  • Diastolic Blood Pressure Measurement

    Change from at baseline weight to 6-weeks

  • Change in Weight

    Change from at baseline weight to 12-weeks

  • Calculation of Body Mass Index (BMI) (kg/m∧2)

    Change from baseline weight to 6-weeks

  • Calculation of BMI (kg/m∧2)

    Change from baseline weight to 12-weeks

  • Concentration of fasted total cholesterol

    Change from baseline weight to 6-weeks

  • +15 more secondary outcomes

Study Arms (2)

Mediterranean diet group

EXPERIMENTAL

Participants will receive both nutrition education on patterns of a Mediterranean style diet as well as olive oil and mixed nuts.

Behavioral: Mediterranean dietDietary Supplement: Olive oil and mixed nuts

American Heart Association group

ACTIVE COMPARATOR

Participants will receive nutrition education on the dietary recommendations for heart health from the American Heart Association.

Behavioral: American Heart Association

Interventions

Participants will receive nutrition education and educational materials from a registered dietitian on patients on the patterns of a Mediterranean style diet. Seven education sessions will be delivered through an online platform. Participants will be asked to complete one education session per week for the first six weeks and the final session at week 9.

Mediterranean diet group
Olive oil and mixed nutsDIETARY_SUPPLEMENT

Participants in the Mediterranean diet group will receive 3 liters of extra-virgin olive oil and 3 pounds of mixed nuts (1.5 pounds raw almonds and 1.5 pounds raw walnuts) at baseline and at 6 weeks. Participants will be educated by oral and written means, on consumption goals of the nuts and olive oil.

Mediterranean diet group

Participants will receive nutrition education and educational materials from a registered dietitian on patients on the dietary recommendations from the American Heart Association for heart health. Seven education sessions will be delivered through an online platform. Participants will be asked to complete one education session per week for the first six weeks and the final session at week 9.

American Heart Association group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Enrolled in Auburn University's health insurance program during the course of the study or a dependent of the enrollee during the course of the study
  • BMI \>24.9 (kg/m2)
  • AND Meets two or more of the following
  • Screening values classified in the "yellow" or "red" zone for:
  • Systolic blood pressure (mmHg): Yellow zone: ≥140, Red zone: ≥160;
  • Diastolic Blood pressure (mmHg): Yellow zone: ≥90, Red zone: ≥ 100;
  • Fasting blood glucose (mm/dL): Yellow zone: ≥100, Red zone: ≥ 126
  • Blood glucose (random) (mg/dL): Yellow zone: 140-200, Red zone \> 200
  • Total Cholesterol (mg/dL): Yellow zone: ≥200, red zone: ≥250
  • Have a pre-existing diagnosis of hypertension, pre-diabetes, or hypercholesterolemia
  • Current smoker (≥1 cigarette/day)
  • Are: male (age: 55-80) or female (age: 60-80)
  • A family history of premature coronary heart disease
  • High risk ethnicity: Black, African American, American Indians/Alaska Natives, Non-Hispanic blacks, Mexican-Americans, Asian, Hispanic/Latino

You may not qualify if:

  • Minors that are less than 19 years of age
  • Individuals who are not enrolled in the Auburn University health insurance program for the 2016 plan year at baseline and have not yet completed initial visit
  • Individuals who have not completed their 2015 "Healthy Tigers" biometric screening between January 1st and December 31st, 2015 (these can be completed by the "Healthy Tigers" staff or by submitting a healthcare provider form from the individuals' physician to the "Healthy Tigers" office), unless enrolled in "TigerMeds".
  • Individuals who are pregnant or who intend to become pregnant during the 12-week health and wellness challenge.
  • Individuals who anticipate absence or travel throughout the study that would interfere with their ability to complete the analysis at the mid-point and end of challenge.
  • Patients with a peanut, tree nut, or olive oil food allergy or intolerance.
  • Patients who are unable or unwilling to travel to Auburn University main campus for live health and wellness challenge events, individual assessments, personal appointments, and pre- and post- data collection
  • Individuals who have NOT been stabilized on medication to treat or manage high blood pressure, high cholesterol, dyslipidemia, or pre diabetes for at least 12 weeks prior to the study.
  • Patients who do not have access to the internet and therefore unable to complete the education portion of the study
  • Individuals who have a pacemaker
  • Patients who decline participation during informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Auburn University Pharmaceutical Care Center

Auburn, Alabama, 36849, United States

Location

MeSH Terms

Conditions

Cardiovascular DiseasesObesity

Interventions

Diet, MediterraneanOlive OilAmerican Heart Association

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaDietary Fats, UnsaturatedDietary FatsFatsLipidsFats, UnsaturatedPlant OilsOilsFoodFood and BeveragesVoluntary Health AgenciesOrganizations, NonprofitOrganizationsHealth Care Economics and Organizations

Study Officials

  • Michael W Greene, PhD

    Auburn University

    STUDY CHAIR
  • Amy W Willis, MS, RD

    Auburn University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Auburn University Metabolic Phenotyping Laboratory

Study Record Dates

First Submitted

September 20, 2018

First Posted

September 25, 2018

Study Start

January 23, 2017

Primary Completion

September 7, 2017

Study Completion

September 7, 2017

Last Updated

September 27, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

Locations